Novo Nordisk's pricing tactics inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of cost gouging, declaring the stark contrast in between U.S. selling prices and those in Europe and copyright.This led Novo Nordisk to perform more investigate into increased dosages of semaglutide specifically